ProfileGDS4718 / 219650_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 57% 47% 44% 46% 44% 74% 73% 38% 48% 55% 50% 49% 65% 75% 70% 51% 51% 78% 69% 52% 45% 53% 55% 54% 59% 61% 46% 63% 46% 74% 62% 66% 40% 36% 60% 65% 69% 49% 47% 46% 50% 66% 54% 71% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9539657
GSM549102patient 115, normal, homogenized [OPG study]5.3703247
GSM549104patient 119, normal, homogenized [OPG study]5.1944844
GSM549108patient 138, normal, homogenized [OPG study]5.3445846
GSM549119patient 077, normal, homogenized [OPG study]5.2260144
GSM549133patient 032, cancer, homogenized [OPG study]7.3579674
GSM549139patient 042, cancer, homogenized [OPG study]7.1341773
GSM549099patient 107, normal, homogenized [OPG study]4.923638
GSM549109patient 139, normal, homogenized [OPG study]5.4368248
GSM549110patient 046, normal, homogenized [OPG study]5.7966255
GSM549114patient 063, normal, homogenized [OPG study]5.4404550
GSM549122patient 082, normal, homogenized [OPG study]5.4549949
GSM549134patient 033, cancer, homogenized [OPG study]6.502365
GSM549136patient 036, cancer, homogenized [OPG study]7.4280675
GSM549140patient 044, cancer, homogenized [OPG study]6.9414270
GSM549111patient 047, normal, homogenized [OPG study]5.5865351
GSM549113patient 057, normal, homogenized [OPG study]5.5383851
GSM549132patient 031, cancer, homogenized [OPG study]7.6376778
GSM549137patient 038, cancer, homogenized [OPG study]6.8449769
GSM549142patient 047, cancer, homogenized [OPG study]5.7401952
GSM549100patient 110, normal, homogenized [OPG study]5.2681645
GSM549107patient 135, normal, homogenized [OPG study]5.6609453
GSM549115patient 068, normal, homogenized [OPG study]5.7340755
GSM549116patient 072, normal, homogenized [OPG study]5.712854
GSM549120patient 078, normal, homogenized [OPG study]6.0519959
GSM549131patient 030, cancer, homogenized [OPG study]6.1776761
GSM549118patient 074, normal, homogenized [OPG study]5.2754146
GSM549129patient 027, cancer, homogenized [OPG study]6.3472163
GSM549123patient 088, normal, homogenized [OPG study]5.2518246
GSM549124patient 006, cancer, homogenized [OPG study]7.1822974
GSM549126patient 015, cancer, homogenized [OPG study]6.2746862
GSM549128patient 025, cancer, homogenized [OPG study]6.6398666
GSM549103patient 117, normal, homogenized [OPG study]5.0326440
GSM549117patient 073, normal, homogenized [OPG study]4.7840336
GSM549138patient 041, cancer, homogenized [OPG study]6.1270660
GSM549141patient 045, cancer, homogenized [OPG study]6.5013665
GSM549130patient 028, cancer, homogenized [OPG study]6.7522169
GSM549101patient 111, normal, homogenized [OPG study]5.4719149
GSM549105patient 128, normal, homogenized [OPG study]5.3938447
GSM549106patient 134, normal, homogenized [OPG study]5.2179846
GSM549112patient 048, normal, homogenized [OPG study]5.5102350
GSM549125patient 011, cancer, homogenized [OPG study]6.5760566
GSM549127patient 024, cancer, homogenized [OPG study]5.7499654
GSM549135patient 035, cancer, homogenized [OPG study]7.0276471